InMed Pharmaceuticals Inc. (INM) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $2.15M | -18.0% |
| 2024 | $2.62M | +29.8% |
| 2023 | $2.02M | -45.6% |
| 2022 | $3.71M | +54.2% |
| 2021 | $2.40M | +25.0% |
| 2020 | $1.92M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $2.15M | -18.0% |
| 2024 | $2.62M | +29.8% |
| 2023 | $2.02M | -45.6% |
| 2022 | $3.71M | +54.2% |
| 2021 | $2.40M | +25.0% |
| 2020 | $1.92M | — |